Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Conditions: COVID-19 Interventions: Biological: GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile) Sponsors: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting

Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials